IN VITRO AZACITIDINE TREATMENT MODIFIES THE PROTEOME OF AML1/ETO POSITIVE LEUKEMIA CELLS

被引：0
|
作者：
Buchi, F. [1 ]
Ferrari, G. [1 ]
Spinelli, E. [1 ]
Gozzini, A. [1 ]
Bosi, A. [1 ]
Lunghi, T. [1 ]
Santini, V [1 ]
机构：
[1] Univ Firenze, AOU Careggi, Florence, Italy
来源：
HAEMATOLOGICA | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P119
引用
收藏
页码：S87 / S87
页数：1
相关论文
共 50 条
  • [1] IN VITRO VALPROIC ACID TREATMENT MODIFIES THE PROTEOME OF AML1/ETO POSITIVE LEUKEMIA CELLS
    Buchi, F.
    Ferrari, G.
    Spinelli, E.
    Gozzini, A.
    Bosi, A.
    Lunghi, T.
    Santini, V
    HAEMATOLOGICA, 2008, 93 : S85 - S85
  • [2] PROTEOMIC MODIFICATIONS INDUCED BY AZACITIDINE IN AML1/ETO POSITIVE LEUKEMIA CELLS
    Santini, V.
    Buchi, F.
    Ferrari, G.
    Spinelli, E.
    Lunghi, T.
    Gozzini, A.
    Bosi, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 207 - 207
  • [3] Targeted Therapy of AML1/ETO-Positive AML Cells in Experimental Model
    Zapotocky, Michal
    Starkova, Julia
    Mejstrikova, Ester
    Smetana, Karel
    Trka, Jan
    BLOOD, 2008, 112 (11) : 1153 - 1153
  • [4] NHR4 domain mutations of ETO are probably very infrequent in AML1–ETO positive myeloid leukemia cells
    B Hackanson
    M Abdelkarim
    J H Jansen
    M Lübbert
    Leukemia, 2010, 24 : 860 - 861
  • [5] Treatment with valproic acid restores differentiation in AML1/ETO-positive leukaemic cells
    Zapotocky, Michal
    Starkova, Julia
    Mejstrikova, Ester
    Smetana, Karel
    Trka, Jan
    BLOOD, 2007, 110 (11) : 141B - 141B
  • [6] Treatment with valproic acid restores differentiation in AML1/ETO-positive leukaemic cells
    Zapotocky, M.
    Starkova, J.
    Mejstrikova, E.
    Smetana, K.
    Trka, J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 42 - 42
  • [7] A Case of AML1/ETO Positive Child with Acute Myeloid Leukemia with Poor Prognosis
    Zhang, Xiaofang
    Wu, Yiping
    Wang, Lihua
    Li, Haixin
    Li, Ruimin
    CLINICAL LABORATORY, 2023, 69 (02) : 410 - 413
  • [8] PIG7, transactivated by AML1, promotes apoptosis and differentiation of leukemia cells with AML1–ETO fusion gene
    J Liu
    H Xing
    Y Chen
    L Wang
    D Wang
    Q Rao
    K Tang
    Z Tian
    K He
    M Wang
    J Wang
    Leukemia, 2012, 26 : 117 - 126
  • [9] The origin of neoplastic mast cells in systemic mastocytosis with AML1/ETO-positive acute myeloid leukemia
    Nagai, Surnimasa
    Ichikawa, Motoshi
    Takahashi, Tsuyoshi
    Sato, Hiroyuki
    Yokota, Hiromitsu
    Shima, Kurni
    Izutsu, Koji
    Hangaishi, Akira
    Kanda, Yoshinobu
    Motokura, Toru
    Chiba, Shigeru
    Yatomi, Yutaka
    Kurokawa, Mineo
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (11) : 1747 - 1752
  • [10] Identification of epigenetic modifiers essential for growth and survival of AML1/ETO-positive leukemia
    Duque-Afonso, Jesus
    Veratti, Pia
    Rehman, Usama-Ur
    Herzog, Heike
    Mitschke, Jan
    Greve, Gabriele
    Eble, Julian
    Berberich, Bettina
    Thomas, Johanna
    Pantic, Milena
    Waterhouse, Miguel
    Gentile, Gaia
    Heidenreich, Olaf
    Miething, Cornelius
    Luebbert, Michael
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (11) : 2068 - 2079
12345